Evaxion A (EVAX) Accounts Payables (2019 - 2025)
Evaxion A posted quarterly Accounts Payables of $2.2 million for Q4 2025, down 26.35% year-on-year from $3.0 million in Q4 2024, and down 12.42% on a QoQ basis from $2.5 million in Q2 2025.
Evaxion A (EVAX) has 7 years of Accounts Payables data on file, last reported at $2.2 million in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables fell 26.35% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (down 26.35% YoY), and the FY2025 full-year result was $2.2 million, down 26.35% from the prior year.
- Accounts Payables for Q4 2025 stood at $2.2 million, down from $2.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $3.4 million in Q1 2021 and bottomed at $538000.0 in Q3 2021.
- The 5-year median for Accounts Payables is $2.5 million (2022), against an average of $2.3 million.
- The widest annual swing landed in 2022, when Accounts Payables surged 57.15%; it then sank 30.91% in 2023.
- A 5-year view of Accounts Payables shows it stood at $2.8 million in 2021, then fell by 26.79% to $2.1 million in 2022, then gained by 28.97% to $2.7 million in 2023, then grew by 10.38% to $3.0 million in 2024, then dropped by 26.35% to $2.2 million in 2025.
- The last three Accounts Payables figures came in at $2.2 million (Q4 2025), $2.5 million (Q2 2025), and $3.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 80.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.19 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Dec 31, 2024 | 2.97 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Dec 31, 2022 | 2.09 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 2.85 Mn |
| Sep 30, 2021 | 538,000.00 |
| Jun 30, 2021 | 1.55 Mn |
| Mar 31, 2021 | 3.41 Mn |
| Dec 31, 2020 | 3.67 Mn |
| Dec 31, 2019 | 646,000.00 |